References
- MehdiZBirnsJBhallaAPost-stroke urinary incontinenceInt J Clin Pract201367111128113723834208
- BrittainKRPeetSMCastledenCMStroke and incontinenceStroke19982925245289472900
- Agency for Health Care Policy and Research (APCHR)Urinary Incontinence Guideline Panel. Urinary Incontinence in Adults: Acute and Chronic Management. Clinical Practice GuidelineRockville, MDUS Department of Health and Human ServicesAPCHR publication no. 96-06821996
- AbramsPCardozoLFallMStandardisation Sub-Committee of the International Continence SocietyThe standardisation of terminology of lower urinary tract function: report from the Standardisation Subcommittee of the International Continence SocietyNeurourol Urodyn200221216717811857671
- NabiGCodyJDEllisGHerbisonPHay-SmithJAnticholinergic drugs versus placebo for overactive bladder syndrome in adultsCochrane Database Syst Rev20064CD00378117054185
- BettezMTu leMCarlsonK2012 update: guidelines for adult urinary incontinence collaborative consensus document for the Canadian urological associationCan Urol Assoc J20126535436323093627
- YamaguchiOAntimuscarinics and overactive bladder: other mechanism of actionNeurourol Urodyn201029111211519693952
- HughesKMLangJCLazareRMeasurement of oxybutynin and its N-desethyl metabolite in plasma, and its application to pharmacokinetic studies in young, elderly and frail elderly volunteersXenobiotica19922278598691455904
- GarelyADBurrowsLJCurrent pharmacotherapeutic strategies for overactive bladderExpert Opin Pharmacother20023782783312083983
- IoannouGNBoykoEJLeeSPThe prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999–2002Am J Gastroenterol20061011768216405537
- BernalWWendonJAcute liver failureN Engl J Med2013369262525253424369077
- SgroCClinardFOuazirKIncidence of drug-induced hepatic injuries: a French population-based studyHepatology200236245145512143055
- NaranjoCABustoUSellersEMA method for estimating the probability of adverse drug reactionsClin Pharmacol Ther19813022392457249508
- BjörnssonESBergmannOMBjörnssonHKKvaranRBOlafssonSIncidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of IcelandGastroenterology201314471419142523419359
- ChangCYSchianoTDReview article: drug hepatotoxicityAliment Pharmacol Ther200725101135115117451560
- Health CanadaCanadian Adverse Drug Reaction Monitoring Program DatabaseOttawa, ONHealth Canada Available from: http://cvp-pcv.hc-sc.gc.ca/arq-rei/index-eng.jspAccessed April 27, 2018
- LiverTox [webpage on the Internet]Adverse Drug Reaction Probability Scale (Naranjo)2017 Available from: https://livertox.nih.gov/Narajo.htmlAccessed January 9, 2018
- BjörnssonEJacobsenEIKalaitzakisEHepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketingJ Hepatol201256237438021889469
- Hey-HadaviJHKuntzeELuoDSilvermanPPittmanDLepetriBTolerability of atorvastatin in a population aged ≥65 years: a retrospective pooled analysis of results from fifty randomized clinical trialsAm J Geriatr Pharmacother20064211212216860258
- de DenusSSpinlerSAMillerKPetersonAMStatins and liver toxicity: a meta-analysisPharmacotherapy200424558459115162892
- VoicanCSCorrubleENaveauSPerlemuterGAntidepressant-induced liver injury: a review for cliniciansAm J Psychiatry2014171440441524362450